Considering that obesity, T2D, and NAFLD share insulin resistance as a common pathophysiologic mechanism20 and that the dominant expression of betatrophin is in human liver12, we hypothesized that circulating betatrophin levels might be elevated in subjects with NAFLD. Here, ANGPTL8 is linked to type 2 diabetes mellitus.